Quartet 1457Q Left Ventricular (LV) Lead Investigational Device Exemption (IDE) Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Heart Center Research
Huntsville, Alabama, United States
- Arizona Arrhythmia Research Center
Phoenix, Arizona, United States
- Cardiology Associates of Northeast Arkansas
Jonesboro, Arkansas, United States
- Scripps Health
La Jolla, California, United States
- Premier Cardiology, Inc.
Newport Beach, California, United States
- Stanford University Hospital
Stanford, California, United States
- Munroe Regional Medical Center
Ocala, Florida, United States
- Tallahassee Research Institute
Tallahassee, Florida, United States
- Emory University Hospital
Atlanta, Georgia, United States
- North Georgia Heart Foundation
Gainesville, Georgia, United States
- Iowa Heart Center
West Des Moines, Iowa, United States
- Central Baptist Hospital
Lexington, Kentucky, United States
- One Health Cardiology
Owensboro, Kentucky, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Thoracic Cardiovascular Healthcare Foundation
Lansing, Michigan, United States
- Missouri Heart Center
Columbia, Missouri, United States
- Catholic Medical Center
Manchester, New Hampshire, United States
- Cardiovascular Associates of Delaware Valley
Haddon Heights, New Jersey, United States
- Forsyth Medical Center
Winston-Salem, North Carolina, United States
- University Hospitals of Cleveland
Cleveland, Ohio, United States
- Oklahoma Heart Institute at Utica
Tulsa, Oklahoma, United States
- Lancaster General Hospital
Lancaster, Pennsylvania, United States
- Donald Guthrie Foundation for Education & Research
Sayre, Pennsylvania, United States
- Greenville Health System
Greenville, South Carolina, United States
- Erlanger Medical Center
Chattanooga, Tennessee, United States
- the Stern Cardiovascular Foundation
Germantown, Tennessee, United States
- the Heart Hospital Baylor Plano
Plano, Texas, United States
- Swedish Medical Center - Heart & Vascular
Seattle, Washington, United States
- St. Mary'S Hospital
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 27 Oct 2015
- Primary completion
- 19 Aug 2016
- Completion
- 21 Mar 2017
- Last update posted
- 4 Feb 2019
- Registered enrollment
- 499
- Registry id
- NCT02548455
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.